Reuters -- Genzyme Corp (GENZ.O) said second-quarter earnings plummeted as manufacturing problems led to shortages of two of its biggest-selling drugs, sending its shares down 1.7 percent in premarket trading.
Reuters -- Genzyme Corp (GENZ.O) said second-quarter earnings plummeted as manufacturing problems led to shortages of two of its biggest-selling drugs, sending its shares down 1.7 percent in premarket trading.
